These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 11913728)

  • 1. Polymorphisms in the ABC drug transporter gene MDR1.
    Brinkmann U; Eichelbaum M
    Pharmacogenomics J; 2001; 1(1):59-64. PubMed ID: 11913728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ABC drug transporters: hereditary polymorphisms and pharmacological impact in MDR1, MRP1 and MRP2.
    Kerb R; Hoffmeyer S; Brinkmann U
    Pharmacogenomics; 2001 Feb; 2(1):51-64. PubMed ID: 11258197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C3435T polymorphism in the MDR1 gene affects the enterocyte expression level of CYP3A4 rather than Pgp in recipients of living-donor liver transplantation.
    Goto M; Masuda S; Saito H; Uemoto S; Kiuchi T; Tanaka K; Inui K
    Pharmacogenetics; 2002 Aug; 12(6):451-7. PubMed ID: 12172213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical aspects of the MDR1 (ABCB1) gene polymorphism.
    Eichelbaum M; Fromm MF; Schwab M
    Ther Drug Monit; 2004 Apr; 26(2):180-5. PubMed ID: 15228162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional implications of genetic polymorphisms in the multidrug resistance gene MDR1 (ABCB1).
    Pauli-Magnus C; Kroetz DL
    Pharm Res; 2004 Jun; 21(6):904-13. PubMed ID: 15212152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of MDR1 genetic polymorphisms in interindividual variability in P-glycoprotein expression and function.
    Woodahl EL; Ho RJ
    Curr Drug Metab; 2004 Feb; 5(1):11-9. PubMed ID: 14965248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevance.
    Marzolini C; Paus E; Buclin T; Kim RB
    Clin Pharmacol Ther; 2004 Jan; 75(1):13-33. PubMed ID: 14749689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P-glycoprotein and bioavailability-implication of polymorphism.
    Liu Y; Hu M
    Clin Chem Lab Med; 2000 Sep; 38(9):877-81. PubMed ID: 11097343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional polymorphisms of the human multidrug resistance (MDR1) gene: correlation with P glycoprotein expression and activity in vivo.
    Brinkmann U
    Novartis Found Symp; 2002; 243():207-10; discussion 210-2, 231-5. PubMed ID: 11990778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multidrug resistance 1 gene in inflammatory bowel disease: a meta-analysis.
    Annese V; Valvano MR; Palmieri O; Latiano A; Bossa F; Andriulli A
    World J Gastroenterol; 2006 Jun; 12(23):3636-44. PubMed ID: 16773678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MDR1 G1199A polymorphism alters permeability of HIV protease inhibitors across P-glycoprotein-expressing epithelial cells.
    Woodahl EL; Yang Z; Bui T; Shen DD; Ho RJ
    AIDS; 2005 Oct; 19(15):1617-25. PubMed ID: 16184031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphisms of the drug transporters ABCB1, ABCG2, ABCC2 and ABCC3 and their impact on drug bioavailability and clinical relevance.
    Bruhn O; Cascorbi I
    Expert Opin Drug Metab Toxicol; 2014 Oct; 10(10):1337-54. PubMed ID: 25162314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation and prevention of multidrug resistance by inhibitors of P-glycoprotein.
    Sikic BI; Fisher GA; Lum BL; Halsey J; Beketic-Oreskovic L; Chen G
    Cancer Chemother Pharmacol; 1997; 40 Suppl():S13-9. PubMed ID: 9272128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic polymorphisms of the human MDR1 drug transporter.
    Schwab M; Eichelbaum M; Fromm MF
    Annu Rev Pharmacol Toxicol; 2003; 43():285-307. PubMed ID: 12359865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure, function, expression, genomic organization, and single nucleotide polymorphisms of human ABCB1 (MDR1), ABCC (MRP), and ABCG2 (BCRP) efflux transporters.
    Choudhuri S; Klaassen CD
    Int J Toxicol; 2006; 25(4):231-59. PubMed ID: 16815813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenomics of MDR1/ABCB1 gene: the influence on risk and clinical outcome of haematological malignancies.
    Jamroziak K; Robak T
    Hematology; 2004 Apr; 9(2):91-105. PubMed ID: 15203864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of BCRP/MXR, MRP1 and MDR1/P-Glycoprotein on thermoresistant variants of atypical and classical multidrug resistant cancer cells.
    Stein U; Lage H; Jordan A; Walther W; Bates SE; Litman T; Hohenberger P; Dietel M
    Int J Cancer; 2002 Feb; 97(6):751-60. PubMed ID: 11857350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidrug resistance: molecular mechanisms and clinical relevance.
    Ling V
    Cancer Chemother Pharmacol; 1997; 40 Suppl():S3-8. PubMed ID: 9272126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug transporters in HIV Therapy.
    Kim RB
    Top HIV Med; 2003; 11(4):136-9. PubMed ID: 12876331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of P-glycoprotein transport function and reversion of MDR1 multidrug resistance by cnidiadin.
    Barthomeuf C; Grassi J; Demeule M; Fournier C; Boivin D; Béliveau R
    Cancer Chemother Pharmacol; 2005 Aug; 56(2):173-81. PubMed ID: 15824923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.